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Abstract
Background: Enrolment of patients into a randomised controlled trial (RCT) in violation of key inclusion or
exclusion criteria, may lead to excess avoidable harm. The purpose of this paper was to systematically identify and
review techniques and interventions proven to prevent or avoid inappropriate enrolment of patients into RCTs.
Methods: EMBASE, MEDLINE, Cochrane Database of Systematic Reviews, Cochrane Methodology Register, online
abstract repositories, and conference websites were searched. Experts were contacted and bibliographies of
retrieved papers hand-searched. The search cut-off date was 31 August 2009.
Results: No primary publications were found. We identified one study in the grey literature (conference abstracts
and presentations) reporting the results of an evaluation of the effectiveness of an intervention designed to
prevent or avoid inappropriate enrolment of patients into an RCT. In the context of a multicentre trial, use of a
dummy enrolment run-in phase was shown to reduce enrolment errors significantly (P < 0.001), from 16.1% during
the run-in phase to < 1% after trial initiation.
Conclusions: Our systematic search yielded only one technique or intervention shown to improve adherence to
eligibility criteria during enrolment into RCTs. Given the potential harm involved in recruiting patients into a clinical
trial in violation of key eligibility criteria, future research is needed to better inform those conducting clinical trials
of how best to prevent enrolment errors
Background
Within the context of a clinical trial, the primary pur-
pose of defining clear, objective and precise study elig-
ibility criteria is to facilitate the repeatable inclusion of
patients who are thought most likely to benefit from
the new drug or intervention under study, and to allow
the exclusion of patients thought most likely to be
harmed [1]. Inappropriate enrolment of patients in vio-
lation of key eligibility criteria may lead to excess avoid-
able harm to those patients, which may include serious
adverse events or even death, attributable to the use of
the study intervention in patients with important con-
traindications [2]. For the purpose of this review, we
defined such an inappropriate enrolment as an enrol-
ment error, and for the sake of clarity we defined the
term ‘eligibility criteria’ to include both inclusion and
exclusion criteria.
Authoritative sources recom m e n dt h a ti ft h ep r o p o r -
tion of ineligible patients recruited into a clinical trial
exceeds 10%, the trial organisation should be considered
to be ‘generally poor’ and may need ‘tightening up’ [1].
An overall estimate of enrolment error rates from clini-
cal trials conducted in all disciplines of medicine is una-
vailable. In the discipline of intensive care medicine,
enrolment error rates reported by multicentre Food and
Drug Administration (FDA) licensing trials range from
9.4% (159/1690) [2] to 16.5% (77/464) [3]. Furthermore,
evidence exists to suggest that enrolment errors may be
preventable [2].
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occurs when a new site recruits their first patient into a
new trial. The first-patient enrolment error rate may be
double the error rate for any subsequent patients [2].
Because site-specific enrolment errors have been shown
to decrease as the number of patients enrolled at a site
increases, the presence of a ‘learning curve’ has been
proposed. As a site gains experience with the application
of a particular study’s eligibility criteria, they learn how
to more appropriately apply each unique study inclusion
and exclusion criterion, and are thus able to prevent or
avoid enrolment errors [2]. Because the prevention or
avoidance of enrolment errors may reduce avoidable
harm, prevention or avoidance should take precedence
over post-error detection [1].
The purpose of this review was to systematically iden-
tify studies evaluating the effectiveness of techniques or
interventions designed to prevent or avoid enrolment
errors during recruitment into randomised controlled
trials (RCTs).
Methods
Primary literature search
To detect papers reporting the effectiveness of interven-
tions designed to reduce enrolment errors in clinical
trials, our primary search was conducted using MED-
LINE http://www.PubMed.org, EMBASE http://www.
EMBASE.com, the Cochrane Database of Systematic
Reviews and the Cochrane Methodology Register http://
www.mrw.interscience.wiley.com/cochrane/. Bibliogra-
phies of retrieved papers were also hand searched.
The primary search strategy was developed to identify
any publication that reported protocol violations, proto-
col adherence or other related concepts. A complete list
of these concept-related terms is presented in Table 1.
In MEDLINE, concept-related terms were crossed with
sensitive (broad) statements to identify clinical trials
publications [4] and with the MeSH term ‘clinical trials
as topic’.A ne x a m p l eo fo n eo ft h em a i nM E D L I N E
search strategies is provided in Additional file 1. In
searches of other databases, all search strategies and
terms developed for MEDLINE were mapped to data-
base-specific indexing terms (for example, MeSH terms
were mapped to EMTREE terms). EMTREE concept-
related terms were crossed with sensitive (broad)
EMTREE statements to identify publications related to
clinical trials [5]. A complete list of terms and strategies
developed for each database is available upon request
from the authors.
Grey literature search
To identify the grey literature (for example, abstracts
and presentations), we reviewed our own copies of con-
ference booklets and searched for online abstract
repositories. Conferences on the topic of clinical trials
were identified by visiting recognized international
society websites and by conducting a primary web
search using the search engine Google http://www.goo-
gle.com. These searches were conducted independently
by two authors (EAS and GSD).
We also contacted recognised experts in the field. We
defined ‘recognised experts’ as individuals with extensive
experience in the design and conduct of clinical trials
with a known interest in, or publications on, the topic
of protocol violations. Expert consultation was con-
ducted over several years, and took the form of informal
discussions at conferences, management committee
meetings and other venues, with the intent of learning
how to reduce protocol violations.
Search limits and date
The search was not limited by language or study type.
The cut-off date was 31 August 2009.
Study selection
All identified abstracts were independently reviewed by
at least two authors (EAS and GSD), who were not
blinded to publication source or abstract author list.
Any abstract that either author believed was describing
an intervention designed to reduce any form of protocol
error or violation was retrieved in full text for detailed
review. Non-English abstracts were translated.
An enrolment error was defined as the recruitment of
a patient into a clinical trial in violation of an explicit,
known eligibility criterion. Only papers reporting enrol-
ment errors were eligible for further consideration. All
techniques and interventions recommended to prevent
Table 1 Search terms used in the primary literature
search.
Databases Specific search
terms used
MEDLINE using Pubmed
a; EMBASE
b; Cochrane
Database of Systematic Reviews
Protocol violation
Recruitment
violation
Enrolment violation
Recruitment error
Protocol error
Enrolment error
Protocol adherence
Protocol compliance
Recruitment
adherence
aEach of the terms were crossed (Boolean AND) with the Medline strategy
described by Haynes et al. [4] for detecting RCTs. In addition, each was also
crossed with the MeSH term ‘clinical trials as topic’.
bEach of the terms were crossed (Boolean AND) with the EMBASE strategy
described by Wong et al. [5] for detecting RCTs.
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form of evaluation of effectiveness was accepted.
Detailed, unblinded review of full text papers was
independently conducted by all three authors (FS, EAS
and GSD). Disagreements regarding paper inclusion
were resolved by discussion and consensus. For each
included paper, the following data items were indepen-
dently extracted by two authors (FS, GSD): description
of technique or intervention used to prevent/reduce
enrolment errors, type of study undertaken to evaluate
effectiveness of the technique or intervention in prevent-
ing or reducing enrolment errors, key design character-
istics relevant to type of study, results of the evaluation
in the context of specific outcomes reported, and
description of the clinical population and the clinical
treatment intervention type targeted to reduce enrol-
ment errors (for example, medical discipline surgical
intervention).
Results
Primary literature search
Search of MEDLINE, EMBASE, the Cochrane Database
of Systematic Reviews and the Cochrane Methodology
Register yielded 1187 unique, potentially relevant
abstracts. On review, 67 full text papers were retrieved
and reviewed in detail. No papers on the topic were
identified by the primary search. Figure 1 provides a
complete description of the selection process.
Grey literature search
Recognised International society websites such as those
of the Society for Clinical Trials [http://www.sctweb.org,
accessed 26 October 2009], the International Society for
Clinical Biostatistics [http://www.iscb.info, accessed 26
October 2009] and the Pharmaceutical Users Software
Exchange [http://www.phuse.eu, accessed 26 October
2009] were found to be useful portal sites for identifying
conferences on topic.
Although most conference websites published the
titles of invited talks, and many academic conference
websites provided access to the invited speakers’ slides,
no conference websites provided access to searchable
abstract repositories. When available, titles of talks and
abstracts were hand-searched. No talks or abstracts on
topic were identified by the online search. One on-topic
abstract was identified through contact with experts and
review of conference booklets [6] (Figure 1). Complete
agreement was reached on which studies should be
included.
Included studies
Dummy enrolment run-in phase
The results of this evaluation were published in abstract
form only [6], and access to the complete content of the
authors’ slide presentation was provided [http://www.
evidencebased.net/files/doig_runinphasever2.pdf,
accessed 1 November 2009]. This evaluation was per-
formed in the context of a multicentre RCT conducted
in the intensive care units (ICUs) of 32 metropolitan
and community hospitals throughout Australia and New
Zealand (Australia and New Zealand Clinical Trials Reg-
istry, number 012605000704695).
The dummy enrolment run-in phase was undertaken
before the formal live initiation of the study at each of
the 32 participating ICUs, after site investigators and
research coordinators attended 2-day educational study
start-up meetings. During the dummy enrolment run-in
phase, the sites screened patients for eligibility and
applied the key inclusion and exclusion criteria to iden-
tify patients they believed to be eligible for the trial. De-
identified demographic and eligibility information was
submitted to the trial’s clinical coordinating centre
(CCC) using a secure, password-protected, encrypted
study website. Patients in the run-in phase were not
allocated to groups (treatment or control). Upon sub-
mission, the CCC reviewed the patient and provided
timely feedback about their appropriateness for trial
recruitment. After a site had submitted three consecu-
tive truly eligible patients, the site was made ‘live’,a n d
was able to begin recruiting and randomising patients
into the trial.
During the dummy run-in phase, 32 sites submitted
199 potentially eligible patients for adjudication by the
CCC. The median number of patients submitted per site
was 4, (range 3 to 21). Thirteen sites progressed through
the run-in phase without encountering enrolment
errors. Two sites were required to submit 21 patients
each before 3 consecutive truly eligible patients were
identified at either site. The overall enrolment error rate
during the dummy enrolment run-in phase was 16.1%
(32/199).
As of June 2008, 409 patients had been formally
recruited and randomised into the ‘live’ trial. The overall
enrolment error rate during the actual conduct of the
trial was 1% (4/409). Compared with the dummy enrol-
ment run-in phase, enrolment error rates were signifi-
cantly lower during the conduct of the actual trial (32/
16 vs 4/409, P < 0.001, c
2 test).
Discussion
We conducted a comprehensive and thorough search to
identify studies evaluating the effectiveness of techniques
or interventions designed to prevent or avoid enrolment
errors during patient recruitment into RCTs. This
included an attempt to search the grey literature (con-
ference abstracts and presentations). No primary publi-
cations on this topic were found. We identified one
study reported in the grey literature presenting the
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vention (a dummy enrolment run-in phase) designed to
prevent or avoid enrolment errors in a clinical trial. In
the context of a multicentre clinical trial, use of such an
intervention could significantly reduce enrolment errors;
in this report, from 16.1% during the run-in phase to <
1% after trial initiation (P < 0.001).
Background
The conduct of multicentre clinical trials is expensive,
and the costs are increasing at an alarming rate.
Accounting for all costs of development (including the
costs of therapies that are not successful at the FDA
phase I, II or III licensing stages, but not including mar-
keting costs), the 1999 costs of successfully licensing
one new drug or therapy under the FDA scheme have
been estimated at US$500 million [7]. In 2009, discount-
ing for inflation, these costs were estimated at more
than US$1,000 million dollars [7]. Interestingly, over the
same time period, the rate at which FDA phase III clini-
cal trials failed to demonstrate expected benefits (nega-
tive trials) has risen from 20% in the 1990s to nearly
Figure 1 The literature search study selection process.
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son why trials fail to demonstrate expected benefits,
even if benefits truly exist [2].
Excessive protocol violations may result in safety
issues that can cause multicentre clinical trials to be
stopped prematurely [8]. Data from multicentre FDA
phase III licensing trials show that patients enrolled
with protocol violations may experience harm, even
death [2]. Furthermore, this harm may dilute treatment
effects, leading to negative results or early trial cessation
[9]. Examples of protocol violations include failure of
the researchers to deliver the study intervention accord-
ing to the study protocol, noncompliance of patient par-
ticipants with the study protocol, issues relating to
informed consent, and inappropriate enrolment of
patients into the trial who did not meet the trial eligibil-
ity criteria. Of these various types of protocol violations,
evidence suggests that enrolment in contradiction of key
eligibility criteria (enrolment errors) can result in the
greatest patient harm [2]. For example, if a protocol vio-
lation occurs because investigators fail to deliver any of
the active study treatment, no direct patient harm is
caused; however if a patient with a known contraindica-
tion to the study treatment is enrolled, the risk of harm
is real.
Although it is recommended that study eligibility cri-
teria should be clear, objective and precise [1], they are
often complex and open to interpretation. In our own
personal experiences, a CCC must dedicate considerable
time during the early stages of a multicentre trial to
ensure that interpretation is consistent between sites.
Indeed, compelling evidence demonstrates that the risk
of enrolment errors is highest early in a trial, and
decreases as study sites gain experience in enrolling
patients [2,9]. This apparent learning curve, combined
with the possibility of harm from inappropriate enrol-
ment, begs the question: how can we get to the flat end
of the learning curve faster?
The dummy enrolment run-in phase
Medical simulation exercises, such as performing cardio-
pulmonary resuscitation on a mannequin, can create a
realistic learning environment without patient risk.
Simulations have been shown to change practice,
increase compliance with guidelines, and improve team
dynamics [10]. Like a simulation exercise, a dummy
enrolment run-in phase in an RCT replicates the screen-
ing and patient identification process in a protected and
interactive learning environment, without patient risk.
The dummy enrolment run-in phase is conducted
after the provision of education at a study start-up
meeting but before an enrolment website is made ‘live’.
During the dummy enrolment run-in phase, sites gain
practical experience applyin gt h en e ws t u d ye l i g i b i l i t y
criteria by attempting to correctly identify patients they
believe to be eligible for the trial and submitting these
patients to the trial’s CCC for adjudication on appropri-
ateness. Because these patients are not formally enrolled
or randomised, risk of harm is avoided. The dummy
enrolment run-in phase allows participating sites to
learn, by direct first-hand experience, how to apply and
interpret novel inclusion and exclusion criteria [11].
If a site submits a patient that is inappropriate to
enrol, the CCC is provided with an opportunity to pro-
vide immediate nonpunitive positive feedback and edu-
cation on that particular patient. The dummy enrolment
run-in phase also allows the CCC to identify sites that
may have major problems with trial execution. These
sites can be targeted and provided with more detailed
multifaceted educational strategies, including educa-
tional outreach visits and formal one to one academic
detailing [12,13], before making the study live. Further-
more, the dummy enrolment run-in phase allows the
CCC to learn as well.
The CCC can use the dummy enrolment run-in phase
to identify inclusion or exclusion criteria that are too
complex, open to different interpretation or poorly
worded. These problematic criteria can be addressed by
providing additional information to all sites using a ‘fre-
quently asked questions’ (FAQ) publication. The CCC
may also elect to rewrite problematic criteria or to
change the focus or content of future education on the
topic. The dummy enrolment run-in phase provides the
opportunity to refine CCC processes and address elig-
ibility criteria issues before the trial goes live.
The conduct of a dummy enrolment run-in phase
increases the overall duration, and therefore the costs, of a
clinical trial. The ideal duration of the run-in phase must
therefore be balanced against these costs. The publications
by Macias et al. and Laterre et al. both present evidence of
a ‘learning curve’, whereby more protocol violations occur
early during a clinical trial, and suggest that error rates are
minimised after a site recruits at least four patients [2,9].
The presence of learning curves, describing how complica-
tions are reduced as experience increases, have been
reported for many laparoscopic and other surgical proce-
dures [14-16]. It is likely that the ideal duration of a
dummy enrolment run-in phase varies based on the com-
plexity of the eligibility criteria and on other trial factors.
Publications of enrolment errors and other protocol viola-
tions by patient recruitment numbers should be encour-
aged to assist those conducting trials in determining the
appropriate duration of a dummy enrolment run-in for
their given speciality, discipline or type of trial.
Strengths and limitations
The primary literature search, conducted using PubMed,
EMBASE and Cochrane database, was designed to be
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interest. We are reasonably certain that our negative
search results are reliable. Because we acknowledged
that it was possible the primary literature search would
yield few results, we believed it was important to search
the grey literature as well, and, for the purposes of this
study, focused this ‘grey literature search towards identi-
fying conference abstracts and presentations [17].
Hand-searching for conference abstracts is known to
be time-consuming, expensive and difficult [18]. Our
grey literature search for online abstract repositories was
unrewarding. Because conference websites are not
indexed using standardised terms, it is likely that our
search missed important meetings. Online abstract repo-
sitories were uncommon, even though the technology
for providing access to abstracts in a searchable format
is readily available. For example, posting the abstract to
the conference website in a portable document format
(PDF) that is indexed by Google Scholar (http://scholar.
google.com.au, accessed 26 October 2009) would effec-
tively create an online searchable repository. We
strongly recommend that academic conferences publish
accepted abstracts on their conference website in a for-
mat that allows indexing and thus searching, by search
engines such as Google Scholar.
Conclusions
We undertook a comprehensive literature search with the
express purpose of identifying techniques or interven-
tions demonstrated to avoid or prevent enrolment errors
during recruitment into RCTs. No primary publications
on this topic were found. A search of the grey literature
revealed one abstract evaluating the effect of a dummy
enrolment run-in phase on preventing enrolment errors
in a multicentre RCT, which was found to significantly
prevent enrolment errors after trial initiation.
Given the potential for harm when a patient is inap-
propriately enrolled into a clinical trial, the lack of
research in this field is concerning. Further research is
needed to identify and validate other techniques and
interventions that can prevent or avoid enrolment
errors. Research is also needed to identify factors, such
as lack of peer review, number of participating sites, and
overall trial size or budget, which may predispose a trial
to excessive enrolment errors. As an initial step, we
recommend that those conducting clinical trials begin
reporting protocol errors by type in the primary results
publications of clinical trials.
Additional file 1: Appendix 1. Example of a main search strategy, in
MEDLINE syntax.
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